Cargando…

Comparative phase I randomized open-label pilot clinical trial of Gynophilus(®) (Lcr regenerans(®)) immediate release capsules versus slow release muco-adhesive tablets

Gynophilus(®) (Lcr regenerans(®)) is a live biotherapeutic product (LBP) that contains the live biotherapeutic microorganism Lactobacillus rhamnosus Lcr35(®), which is indicated to restore vaginal health. The aim of the study was to compare the safety, ease of use, and compliance of two formulations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dausset, Caroline, Patrier, Stéphane, Gajer, Pawel, Thoral, Claudia, Lenglet, Yann, Cardot, Jean-Michel, Judlin, Philippe, Ravel, Jacques, Nivoliez, Adrien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154122/ https://www.ncbi.nlm.nih.gov/pubmed/30032443 http://dx.doi.org/10.1007/s10096-018-3321-8

Ejemplares similares

Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism Lactobacillus rhamnosus Lcr35(®) in the Invertebrate Model Caenorhabditis elegans: First Mechanistic Insights
por: Poupet, Cyril, et al.
Publicado: (2019)

Effect of vaginal probiotics containing Lactobacillus casei rhamnosus (Lcr regenerans) on vaginal dysbiotic microbiota and pregnancy outcome, prospective, randomized study
por: Petricevic, Ljubomir, et al.
Publicado: (2023)

Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights
por: Poupet, Cyril, et al.
Publicado: (2019)

Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35
por: Dausset, Caroline, et al.
Publicado: (2020)

Mechanistic Approach to Stability Studies as a Tool for the Optimization and Development of New Products Based on L. rhamnosus Lcr35® in Compliance with Current Regulations
por: Muller, Claudia, et al.
Publicado: (2013)

Vaginal Impact of the Oral Administration of Total Freeze-Dried Culture of LCR 35 in Healthy Women
por: Bohbot, J. M., et al.
Publicado: (2012)

In vivo investigation of Lcr35(®) anti-candidiasis properties in Caenorhabditis elegans reveals the involvement of highly conserved immune pathways
por: Poupet, Cyril, et al.
Publicado: (2022)

Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet
por: Lee, Soyoung, et al.
Publicado: (2018)

Impact of Tablet Shape on Drug Dissolution Rate Through Immediate Released Tablets
por: Molavi, Fatima, et al.
Publicado: (2020)

The impact of viscosity on the dissolution of naproxen immediate-release tablets
por: Hassan, Dastan Salim, et al.
Publicado: (2022)

The Effect of Humidity on the Dissolution Kinetics and Tablet Properties of Immediate-Release Tablet Formulation Containing Lamotrigine
por: Lalić-Popović, Mladena, et al.
Publicado: (2022)

LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis
por: Fei, Keke, et al.
Publicado: (2021)

Utilization of Pectin from Okra as Binding Agent in Immediate Release Tablets
por: Owusu, Frederick W. A., et al.
Publicado: (2021)

Development of a 3D Printed Coating Shell to Control the Drug Release of Encapsulated Immediate-Release Tablets
por: Algahtani, Mohammed S., et al.
Publicado: (2020)

Penicillin in Muco-Purulent Conjunctivitis
por: Puttanna, S. T.
Publicado: (1951)

Treatment of Muco-Membranous Colitis
Publicado: (1904)

Development of muco-adhesive orally disintegrating tablets containing tamarind gum-coated tea powders for oral care
por: Kiniwa, Rika, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats
por: Resztak, M, et al.
Publicado: (2014)

At-line porosity sensing for non-destructive disintegration testing in immediate release tablets
por: Bawuah, Prince, et al.
Publicado: (2023)

Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
por: Ait Abdellah, Samira, et al.
Publicado: (2023)

Comparative release profile of sustained release matrix tablets of verapamil HCl
por: Mathur, Vikas, et al.
Publicado: (2013)

External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
por: Poynard, Thierry, et al.
Publicado: (2021)

Pharmacokinetics of Once‐Daily Extended‐Release Tacrolimus Tablets Versus Twice‐Daily Capsules in De Novo Liver Transplant
por: DuBay, Derek A., et al.
Publicado: (2019)

Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin
por: Chua, Hui Ming, et al.
Publicado: (2016)

Immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers
por: Kwak, Seong Shin, et al.
Publicado: (2018)

Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
por: Mitrevska, Ivana, et al.
Publicado: (2019)

Quality by Design Applied Development of Immediate-Release Rabeprazole Sodium Dry-Coated Tablet
por: Lee, Sang-Ho, et al.
Publicado: (2021)

Pharmaceutical Assessment of Melia azedarach Gum as a Binder and Disintegrant in Immediate-Release Tablets
por: Owusu, Frederick William Akuffo, et al.
Publicado: (2022)

Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets
por: Arafat, Mosab, et al.
Publicado: (2023)

Design and characterization of controlled release tablet of metoprolol
por: Singhvi, Gautam, et al.
Publicado: (2012)

Additive Manufacturing of an Extended-Release Tablet of Tacrolimus
por: Abdollahi, Azin, et al.
Publicado: (2023)

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface
por: Matson, Jyl S, et al.
Publicado: (2002)

LcrQ Blocks the Role of LcrF in Regulating the Ysc-Yop Type III Secretion Genes in Yersinia pseudotuberculosis
por: Li, Lamei, et al.
Publicado: (2014)

Carbamazepine extended-release capsules in bipolar disorder
por: Weisler, Richard H
Publicado: (2006)

Nanocomposite capsules with directional, pulsed nanoparticle release
por: Udoh, Christiana E., et al.
Publicado: (2017)

Molecular crystalline capsules that release their contents by light
por: Nagai, Akira, et al.
Publicado: (2021)

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface: correction
por: Matson, Jyl S, et al.
Publicado: (2002)

LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis
por: Poynard, Thierry, et al.
Publicado: (2018)

Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements
por: Markl, Daniel, et al.
Publicado: (2017)

Industrial application of QbD and NIR chemometric models in quality improvement of immediate release tablets
por: Ramadan, Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0p0578rfvpjjgueq4filq1s0gf